-
1
-
-
45549092746
-
Novel drugs and therapeutic targets for severe mood disorders
-
Mathew SJ, Manji HK, Charney DS. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology 2008;33:2080-2092.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 2080-2092
-
-
Mathew, S.J.1
Manji, H.K.2
Charney, D.S.3
-
2
-
-
0030938925
-
Toward an integrated neurobiology of panic disorder
-
discussion, 11-12
-
Goddard AW, Charney DS. Toward an integrated neurobiology of panic disorder. J Clin Psychiatry 1997;58:4-11; discussion 11-12.
-
(1997)
J Clin Psychiatry
, vol.58
, pp. 4-11
-
-
Goddard, A.W.1
Charney, D.S.2
-
3
-
-
2442670195
-
Perturbations in brain monoamine systems during stress
-
Flugge G, Van KM, Mijnster MJ. Perturbations in brain monoamine systems during stress. Cell Tissue Res 2004;315:1-14.
-
(2004)
Cell Tissue Res
, vol.315
, pp. 1-14
-
-
Flugge, G.1
Van, K.M.2
Mijnster, M.J.3
-
4
-
-
0034887389
-
Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders
-
Pacak K, Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Neuroendocrine Rev 2008;22:502-548.
-
(2008)
Neuroendocrine Rev
, vol.22
, pp. 502-548
-
-
Pacak, K.1
Palkovits, M.2
-
5
-
-
0035985549
-
Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress
-
Makino S, Hashimoto K, Gold PW. Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress. Pharmacol Biochem Behav 2002;73:147-158.
-
(2002)
Pharmacol Biochem Behav
, vol.73
, pp. 147-158
-
-
Makino, S.1
Hashimoto, K.2
Gold, P.W.3
-
6
-
-
0033997773
-
Circuits and mechanisms governing hypothalamic responses to stress: A tale of two paradigms
-
Sawchenko PE, Li HY, Ericsson A. Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms. Prog Brain Res 2000;122:61-78.
-
(2000)
Prog Brain Res
, vol.122
, pp. 61-78
-
-
Sawchenko, P.E.1
Li, H.Y.2
Ericsson, A.3
-
7
-
-
0020468095
-
The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat
-
Sawchenko PE, Swanson LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res Rev 1982;4:275-325.
-
(1982)
Brain Res Rev
, vol.4
, pp. 275-325
-
-
Sawchenko, P.E.1
Swanson, L.W.2
-
8
-
-
0022615119
-
Adrenergic innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A combined light and electron microscopic immunocytochemical study
-
Liposits Z, Phelix C, Paull WK. Adrenergic innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A combined light and electron microscopic immunocytochemical study. Histochemistry 1986;84:201-205.
-
(1986)
Histochemistry
, vol.84
, pp. 201-205
-
-
Liposits, Z.1
Phelix, C.2
Paull, W.K.3
-
9
-
-
0023039557
-
A combined light and electron microscopic immunocytochemical method for the simultaneous localization of multiple tissue antigens. Tyrosine hydroxylase immunoreactive innervation of corticotropin releasing factor synthesizing neurons in the paraventricular nucleus of the rat
-
Liposits Z, Sherman D, Phelix C, et al. A combined light and electron microscopic immunocytochemical method for the simultaneous localization of multiple tissue antigens. Tyrosine hydroxylase immunoreactive innervation of corticotropin releasing factor synthesizing neurons in the paraventricular nucleus of the rat. Histochemistry 1986;85:95-106. (Pubitemid 16095191)
-
(1986)
Histochemistry
, vol.85
, Issue.2
, pp. 95-106
-
-
Liposits, Zs.1
Sherman, D.2
Phelix, C.3
Paull, W.K.4
-
10
-
-
0021882086
-
Evidence for local corticotropin releasing factor (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus. An electron microscopic immunohistochemical analysis
-
Liposits Z, Paull WK, Setalo G, et al. Evidence for local corticotropin releasing factor (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus. An electron microscopic immunohistochemical analysis. Histochemistry 1985;83:5-16.
-
(1985)
Histochemistry
, vol.83
, pp. 5-16
-
-
Liposits, Z.1
Paull, W.K.2
Setalo, G.3
-
11
-
-
40749138146
-
The stress system in depression and neurodegeneration: Focus on the human hypothalamus
-
Bao AM, Meynen G, Swaab DF. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev 2008;57:531-553.
-
(2008)
Brain Res Rev
, vol.57
, pp. 531-553
-
-
Bao, A.M.1
Meynen, G.2
Swaab, D.F.3
-
12
-
-
0027358205
-
The functional neuroanatomy of corticotropin-releasing factor
-
discussion 21-29
-
Sawchenko PE, Imaki T, Potter E, et al. The functional neuroanatomy of corticotropin-releasing factor. Ciba Found Symp 1993;172:5-21; discussion 21-29.
-
(1993)
Ciba Found Symp
, vol.172
, pp. 5-21
-
-
Sawchenko, P.E.1
Imaki, T.2
Potter, E.3
-
13
-
-
0021962811
-
Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain
-
Sawchenko PE, Swanson LW. Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed Proc 1985;44:221-227.
-
(1985)
Fed Proc
, vol.44
, pp. 221-227
-
-
Sawchenko, P.E.1
Swanson, L.W.2
-
14
-
-
34548356784
-
Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic
-
Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 2007;10:1116-1124.
-
(2007)
Nat Neurosci
, vol.10
, pp. 1116-1124
-
-
Ressler, K.J.1
Mayberg, H.S.2
-
15
-
-
23244432007
-
An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance
-
DOI 10.1146/annurev.neuro.28.061604.135709
-
Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus-norpeinephrine function: adaptive gain and optimal performance. Ann Rev Neurosci 2005;28:403-450. (Pubitemid 41098911)
-
(2005)
Annual Review of Neuroscience
, vol.28
, pp. 403-450
-
-
Aston-Jones, G.1
Cohen, J.D.2
-
16
-
-
45549108533
-
Noradrenergic modulation of arousal
-
Berridge CW. Noradrenergic modulation of arousal. Brain Res Rev 2008;58:1-17.
-
(2008)
Brain Res Rev
, vol.58
, pp. 1-17
-
-
Berridge, C.W.1
-
17
-
-
26944438305
-
Network reset: A simplified overarching theory of locus coeruleus noradrenaline function. [Review] [61 refs]
-
Bouret S, Sara SJ. Network reset: a simplified overarching theory of locus coeruleus noradrenaline function. [Review] [61 refs]. Trends Neurosci 2005;28:574-582.
-
(2005)
Trends Neurosci
, vol.28
, pp. 574-582
-
-
Bouret, S.1
Sara, S.J.2
-
18
-
-
27844591709
-
Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance
-
DOI 10.1002/cne.20723
-
Aston-Jones G, Cohen JD. Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. [Review] [99 refs]. J Comp Neurol 2005;493:99-110. (Pubitemid 41637975)
-
(2005)
Journal of Comparative Neurology
, vol.493
, Issue.1
, pp. 99-110
-
-
Aston-Jones, G.1
Cohen, J.D.2
-
19
-
-
34447629382
-
Physiology and neurobiology of stress and adaptation: Central role of the brain
-
McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007;87:873-904.
-
(2007)
Physiol Rev
, vol.87
, pp. 873-904
-
-
McEwen, B.S.1
-
20
-
-
0028989937
-
Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors
-
Murugaiah KD, O'Donnell JM. Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 1995;351:483-490.
-
(1995)
Naunyn Schmiedebergs Arch Pharmacol
, vol.351
, pp. 483-490
-
-
Murugaiah, K.D.1
O'donnell, J.M.2
-
21
-
-
0032753979
-
Presynaptic modulation of transmitter release via alpha2-adrenoceptors: Nonsynaptic interactions
-
Vizi ES. Presynaptic modulation of transmitter release via alpha2-adrenoceptors: nonsynaptic interactions. Acta Biol Hung 1999;50:287-295.
-
(1999)
Acta Biol Hung
, vol.50
, pp. 287-295
-
-
Vizi, E.S.1
-
22
-
-
59949089339
-
Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior
-
Zhang HT, Whisler LR, Huang Y, et al. Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior. Neuropsychopharmacology 2009;34:1067-1077.
-
(2009)
Neuropsychopharmacology
, vol.34
, pp. 1067-1077
-
-
Zhang, H.T.1
Whisler, L.R.2
Huang, Y.3
-
23
-
-
22144473378
-
Developmental determinants of sensitivity and resistance to stress
-
Levine S. Developmental determinants of sensitivity and resistance to stress. Psychoneuroendocrinology 2005;30:939-946.
-
(2005)
Psychoneuroendocrinology
, vol.30
, pp. 939-946
-
-
Levine, S.1
-
24
-
-
0023410730
-
Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. II. Adaptation to chronically presented stressful stimuli
-
Abercrombie ED, Jacobs BL. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. II. Adaptation to chronically presented stressful stimuli. J Neurosci 1987;7:2844-2848.
-
(1987)
J Neurosci
, vol.7
, pp. 2844-2848
-
-
Abercrombie, E.D.1
Jacobs, B.L.2
-
25
-
-
0023406643
-
Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and nonstressful stimuli
-
Abercrombie ED, Jacobs BL. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and nonstressful stimuli. J Neurosci 1987;7:2837-2843.
-
(1987)
J Neurosci
, vol.7
, pp. 2837-2843
-
-
Abercrombie, E.D.1
Jacobs, B.L.2
-
26
-
-
0026733895
-
Regulation and dysregulation of the hypothalamicpituitary-adrenal axis. the corticotropin-releasing hormone perspective
-
Chrousos GP. Regulation and dysregulation of the hypothalamicpituitary- adrenal axis. The corticotropin-releasing hormone perspective. Endocrinol Metab Clin North Am 1992;21:833-858.
-
(1992)
Endocrinol Metab Clin North Am
, vol.21
, pp. 833-858
-
-
Chrousos, G.P.1
-
27
-
-
0031872236
-
Stressors, stress, and neuroendocrine integration of the adaptive response. the 1997 hans selye memorial lecture
-
Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci 1998;851:311-335.
-
(1998)
Ann N y Acad Sci
, vol.851
, pp. 311-335
-
-
Chrousos, G.P.1
-
28
-
-
0030992727
-
Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: Effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity
-
Curtis AL, Lechner SM, Pavcovich LA, et al. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J Pharmacol Exp Ther 1997;281:163-172.
-
(1997)
J Pharmacol Exp Ther
, vol.281
, pp. 163-172
-
-
Curtis, A.L.1
Lechner, S.M.2
Pavcovich, L.A.3
-
29
-
-
0028051477
-
Corticotropin-releasing factor neurotransmission in locus coeruleus: A possible site of antidepressant action
-
Curtis AL, Valentino RJ. Corticotropin-releasing factor neurotransmission in locus coeruleus: a possible site of antidepressant action. Brain Res Bull 1994;35:581-587.
-
(1994)
Brain Res Bull
, vol.35
, pp. 581-587
-
-
Curtis, A.L.1
Valentino, R.J.2
-
30
-
-
0033232472
-
Corticotropin-releasing factor, norepinephrine, and stress
-
Koob GF. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 1999;46:1167-1180.
-
(1999)
Biol Psychiatry
, vol.46
, pp. 1167-1180
-
-
Koob, G.F.1
-
31
-
-
0033232493
-
The noradrenergic system in pathological anxiety: A focus on panic with relevance to generalized anxiety and phobias
-
Sullivan GM, Coplan JD, Kent JM, et al. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 1999;46:1205-1218.
-
(1999)
Biol Psychiatry
, vol.46
, pp. 1205-1218
-
-
Sullivan, G.M.1
Coplan, J.D.2
Kent, J.M.3
-
33
-
-
2442673159
-
Life stress, genes, and depression: Multiple pathways lead to increased risk and new opportunities for intervention
-
Charney DS, Manji HK. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE 2004;2004:1-11.
-
(2004)
Sci STKE
, vol.2004
, pp. 1-11
-
-
Charney, D.S.1
Manji, H.K.2
-
34
-
-
34447103169
-
Chronic stress: Implications for neuronal morphology, function, and neurogenesis
-
Joels M, Karst H, Krugers HJ, et al. Chronic stress: implications for neuronal morphology, function, and neurogenesis. Front Neuroendocrin 2007;28:72-96.
-
(2007)
Front Neuroendocrin
, vol.28
, pp. 72-96
-
-
Joels, M.1
Karst, H.2
Krugers, H.J.3
-
35
-
-
1642458476
-
Prefrontal cortical function and anxiety: Controlling attention to threat-related stimuli
-
Bishop S, Duncan J, Brett M, et al. Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nat Neurosci 2004;7:184-188.
-
(2004)
Nat Neurosci
, vol.7
, pp. 184-188
-
-
Bishop, S.1
Duncan, J.2
Brett, M.3
-
36
-
-
34250704200
-
Neurocognitive mechanisms of anxiety: An integrative account
-
Bishop SJ. Neurocognitive mechanisms of anxiety: an integrative account. Trends Cogn Sci 2007;11:307-316.
-
(2007)
Trends Cogn Sci
, vol.11
, pp. 307-316
-
-
Bishop, S.J.1
-
37
-
-
0038659418
-
Alpha2A and alpha2Cadrenoceptor regulation in the brain: Alpha2A changes persist after chronic stress
-
Flugge G, Van KM, Meyer H, et al. Alpha2A and alpha2Cadrenoceptor regulation in the brain: alpha2A changes persist after chronic stress. Eur J Neurosci 2003;17:917-928.
-
(2003)
Eur J Neurosci
, vol.17
, pp. 917-928
-
-
Flugge, G.1
Van, K.M.2
Meyer, H.3
-
38
-
-
33846549248
-
Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: Implications and mechanisms
-
Reber SO, Birkeneder L, Veenema AH, et al. Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: implications and mechanisms. Endocrinology 2007;148:670-682.
-
(2007)
Endocrinology
, vol.148
, pp. 670-682
-
-
Reber, S.O.1
Birkeneder, L.2
Veenema, A.H.3
-
39
-
-
0030813325
-
Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex
-
Kitayama I, Yaga T, Kayahara T, et al. Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biol Psychiatry 1997;42:687-696.
-
(1997)
Biol Psychiatry
, vol.42
, pp. 687-696
-
-
Kitayama, I.1
Yaga, T.2
Kayahara, T.3
-
40
-
-
0037468596
-
Effects of repeated stress on regeneration of serotonergic and noradrenergic axons in the cerebral cortex of adult rats
-
Liu Y, Ishida Y, Shinoda K, et al. Effects of repeated stress on regeneration of serotonergic and noradrenergic axons in the cerebral cortex of adult rats. Neurosci Lett 2003;339:227-230.
-
(2003)
Neurosci Lett
, vol.339
, pp. 227-230
-
-
Liu, Y.1
Ishida, Y.2
Shinoda, K.3
-
41
-
-
43949111673
-
What is the genetic relationship between anxiety and depression?
-
Hettema JM. What is the genetic relationship between anxiety and depression? Am J Med Genet C Semin Med Genet 2008;148:140-146.
-
(2008)
Am J Med Genet C Semin Med Genet
, vol.148
, pp. 140-146
-
-
Hettema, J.M.1
-
42
-
-
0037110646
-
Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: Implications for susceptiblity to stress-related neuropsychiatric disorders
-
Pardon MC, Gould GG, Garcia A, et al. Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptiblity to stress-related neuropsychiatric disorders. Neuroscience 2002;115:229-242.
-
(2002)
Neuroscience
, vol.115
, pp. 229-242
-
-
Pardon, M.C.1
Gould, G.G.2
Garcia, A.3
-
43
-
-
4444355123
-
Role of presynaptic alpha 2-adrenoreceptors in antidepressant action: Recent findings from a microdialysis studies
-
Invernizzi RW, Garattini S. Role of presynaptic alpha 2-adrenoreceptors in antidepressant action: recent findings from a microdialysis studies. Prog Neuro-Psychopharm Biol Psychiatry 2004;28:819-827.
-
(2004)
Prog Neuro-Psychopharm Biol Psychiatry
, vol.28
, pp. 819-827
-
-
Invernizzi, R.W.1
Garattini, S.2
-
44
-
-
33750734353
-
Allostatic load in women with and without PTSD symptoms
-
DOI 10.1521/psyc.2006.69.3.191
-
Glover D, Stuber M, Poland RE. Allostatic load in women with and without PTSD symptoms. Psychiatry 2006;69:191-203. (Pubitemid 44706197)
-
(2006)
Psychiatry
, vol.69
, Issue.3
, pp. 191-203
-
-
Glover, D.A.1
Stuber, M.2
Poland, R.E.3
-
45
-
-
0030960878
-
Plasma catecholamine and lymphocyte beta2-adrenergic receptor alterations in elderly Alzheimer cargivers under stress
-
Mills P, Ziegler M, Patterson T, et al. Plasma catecholamine and lymphocyte beta2-adrenergic receptor alterations in elderly Alzheimer cargivers under stress. Psychosom Med 1997;59:251-256.
-
(1997)
Psychosom Med
, vol.59
, pp. 251-256
-
-
Mills, P.1
Ziegler, M.2
Patterson, T.3
-
46
-
-
58149397540
-
Modeling a negative response bias in the human amygdala by noradrenergicglucocorticoid interactions
-
Kukolja J, Schlapfer TE, Keysers C, et al. Modeling a negative response bias in the human amygdala by noradrenergicglucocorticoid interactions. J Neurosci 2008;28:12868-12876.
-
(2008)
J Neurosci
, vol.28
, pp. 12868-12876
-
-
Kukolja, J.1
Schlapfer, T.E.2
Keysers, C.3
-
47
-
-
33751063546
-
Endogenous cortisol level interacts with noradrenergic activation in the human amygdala
-
DOI 10.1016/j.nlm.2006.05.008, PII S1074742706000773
-
van Stegeren AH, Wolf OT, Everaerd W, et al. Endogenous cortisol level interacts with noradrenergic activation in the human amygdala. Neurobiol Learn Memb 2007;87:57-66. (Pubitemid 44755270)
-
(2007)
Neurobiology of Learning and Memory
, vol.87
, Issue.1
, pp. 57-66
-
-
Van Stegeren, A.H.1
Wolf, O.T.2
Everaerd, W.3
Scheltens, P.4
Barkhof, F.5
Rombouts, S.A.R.B.6
-
48
-
-
41849116700
-
Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder
-
Strawn JR, Geracioti TD Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety 2008;25:260-271.
-
(2008)
Depress Anxiety
, vol.25
, pp. 260-271
-
-
Strawn, J.R.1
Geracioti Jr., T.D.2
-
50
-
-
0142188601
-
Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma
-
Vaiva G, Ducrocq F, Jezequel K, et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry 2003;54:947-949.
-
(2003)
Biol Psychiatry
, vol.54
, pp. 947-949
-
-
Vaiva, G.1
Ducrocq, F.2
Jezequel, K.3
-
51
-
-
40649103412
-
The role of the noradrenergic system in emotional memory
-
van Stegeren AH. The role of the noradrenergic system in emotional memory. Acta Psychol (Amst) 2008;127:532-541.
-
(2008)
Acta Psychol (Amst)
, vol.127
, pp. 532-541
-
-
Van Stegeren, A.H.1
-
52
-
-
33947587104
-
A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder
-
Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry 2007;61:928-934.
-
(2007)
Biol Psychiatry
, vol.61
, pp. 928-934
-
-
Raskind, M.A.1
Peskind, E.R.2
Hoff, D.J.3
-
53
-
-
33947580183
-
The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder
-
Krystal AD, Davidson JR. The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry 2007;61:925-927.
-
(2007)
Biol Psychiatry
, vol.61
, pp. 925-927
-
-
Krystal, A.D.1
Davidson, J.R.2
-
54
-
-
0037315260
-
Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: A placebo-controlled study
-
RaskindMA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry 2003;160:371-373.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 371-373
-
-
Raskind, M.A.1
Peskind, E.R.2
Kanter, E.D.3
-
55
-
-
33644820533
-
Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder
-
Taylor FB, Lowe K, Thompson C, et al. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Biol Psychiatry 2006;59: 577-581.
-
(2006)
Biol Psychiatry
, vol.59
, pp. 577-581
-
-
Taylor, F.B.1
Lowe, K.2
Thompson, C.3
-
56
-
-
34247156174
-
Pharmacologic reduction of CNS noradrenergic activity in PTSD: The case for clonidine and prazosin
-
Boehnlein JK, Kinzie JD. Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin. J Psychiatr Pract 2007;13:72-78.
-
(2007)
J Psychiatr Pract
, vol.13
, pp. 72-78
-
-
Boehnlein, J.K.1
Kinzie, J.D.2
-
58
-
-
0020605682
-
Anxiety syndromes and their relationship to depressive illness
-
Fawcett J, Kravitz HM. Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 1983;44:8-11.
-
(1983)
J Clin Psychiatry
, vol.44
, pp. 8-11
-
-
Fawcett, J.1
Kravitz, H.M.2
-
59
-
-
0030954202
-
Anxious depression in elderly patients. Response to antidepressant treatment
-
Flint AJ, Rifat SL. Anxious depression in elderly patients. Response to antidepressant treatment. Am J Geriatr Psychiatry 1997;5:107-115.
-
(1997)
Am J Geriatr Psychiatry
, vol.5
, pp. 107-115
-
-
Flint, A.J.1
Rifat, S.L.2
-
60
-
-
70349256153
-
Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse
-
Simon NM. Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse. J Clin Psychiatry 2009;70:10-14.
-
(2009)
J Clin Psychiatry
, vol.70
, pp. 10-14
-
-
Simon, N.M.1
-
61
-
-
42449114896
-
Anxious depression and response to treatment
-
Nelson JC. Anxious depression and response to treatment. Am J Psychiatry 2008;165:297-299.
-
(2008)
Am J Psychiatry
, vol.165
, pp. 297-299
-
-
Nelson, J.C.1
-
62
-
-
42449118921
-
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report
-
Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 2008;165:342-351.
-
(2008)
Am J Psychiatry
, vol.165
, pp. 342-351
-
-
Fava, M.1
Rush, A.J.2
Alpert, J.E.3
-
63
-
-
0034883568
-
Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder
-
Silverstone PH, Salinas E. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. J Clin Psychiatry 2001;62:523-529.
-
(2001)
J Clin Psychiatry
, vol.62
, pp. 523-529
-
-
Silverstone, P.H.1
Salinas, E.2
-
64
-
-
0029829648
-
Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders
-
Brown C, Schulberg HC, Madonia MJ, et al. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996;153:1293-1300. (Pubitemid 26334202)
-
(1996)
American Journal of Psychiatry
, vol.153
, Issue.10
, pp. 1293-1300
-
-
Brown, C.1
Schulberg, H.C.2
Madonia, M.J.3
Shear, M.K.4
Houck, P.R.5
-
65
-
-
0034978328
-
Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression
-
Russell JM, Koran LM, Rush J, et al. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress Anxiety 2001;13:18-27.
-
(2001)
Depress Anxiety
, vol.13
, pp. 18-27
-
-
Russell, J.M.1
Koran, L.M.2
Rush, J.3
-
66
-
-
34548304880
-
The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: A post-hoc analysis of an open-label outpatient study
-
Fava M, Martinez JM, Greist J, et al. The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study. Ann Clin Psychiatry 2007;19:187-195.
-
(2007)
Ann Clin Psychiatry
, vol.19
, pp. 187-195
-
-
Fava, M.1
Martinez, J.M.2
Greist, J.3
-
67
-
-
36448931969
-
Anxious-depressive comorbidity: Effects on HPA axis and CNS noradrenergic functions. [Review] [74 refs]
-
Cameron OG. Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions. [Review] [74 refs]. Essential Psychopharmacol 2006;7:24-34.
-
(2006)
Essential Psychopharmacol
, vol.7
, pp. 24-34
-
-
Cameron, O.G.1
-
68
-
-
20344381561
-
Interaction of brain noradrenergic system and the hypothalamic-pituitary- adrenal (HPA) axis in man
-
Young EA, Abelson JL, Cameron OG. Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man. Psychoneuroendocrinology 2005;30:807-814.
-
(2005)
Psychoneuroendocrinology
, vol.30
, pp. 807-814
-
-
Young, E.A.1
Abelson, J.L.2
Cameron, O.G.3
-
69
-
-
0031777231
-
The relationship between plasma MHPG and NE: Employing regression models in estimating centrally derived MHPG and peripheral NE turnover rate in panic disorder
-
Gurguis GN, Uhde TW. The relationship between plasma MHPG and NE: employing regression models in estimating centrally derived MHPG and peripheral NE turnover rate in panic disorder. J Psychiatr Res 1998;32:11-17.
-
(1998)
J Psychiatr Res
, vol.32
, pp. 11-17
-
-
Gurguis, G.N.1
Uhde, T.W.2
-
70
-
-
0033232510
-
Role of norepinephrine in the pathophysiology and treatment of mood disorders
-
Ressler KJ, Nemeroff CB. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry 1999;46:1219-1233.
-
(1999)
Biol Psychiatry
, vol.46
, pp. 1219-1233
-
-
Ressler, K.J.1
Nemeroff, C.B.2
-
71
-
-
0033846211
-
Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness
-
Lambert G, Johansson M, Agren H, et al. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness. Arch Gen Psychiatry 2000;57:787-793.
-
(2000)
Arch Gen Psychiatry
, vol.57
, pp. 787-793
-
-
Lambert, G.1
Johansson, M.2
Agren, H.3
-
72
-
-
0035564446
-
Noradrenergic pathology in psychiatric disorders: Postmortem studies
-
Ordway GA, Klimek V. Noradrenergic pathology in psychiatric disorders: postmortem studies. CNS Spectrums 2001;6:697-703.
-
(2001)
CNS Spectrums
, vol.6
, pp. 697-703
-
-
Ordway, G.A.1
Klimek, V.2
-
73
-
-
0038102798
-
Noradrenaline in mood and anxiety disorders: Basic and clinical studies
-
Brunello N, Blier P, Judd LL, et al. Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int Clin Psychopharmacol 2003;18:191-202.
-
(2003)
Int Clin Psychopharmacol
, vol.18
, pp. 191-202
-
-
Brunello, N.1
Blier, P.2
Judd, L.L.3
-
74
-
-
0033914936
-
Norepinephrine dyfunction in depression
-
Anand A, Charney DS. Norepinephrine dyfunction in depression. J Clin Psychiatry 2007;61:16-24.
-
(2007)
J Clin Psychiatry
, vol.61
, pp. 16-24
-
-
Anand, A.1
Charney, D.S.2
-
75
-
-
0025949955
-
Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: Alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men
-
Devesa J, Diaz MJ, Tresguerres JA, et al. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men. J Clin Endocrinol Metab 1991;73:251-256.
-
(1991)
J Clin Endocrinol Metab
, vol.73
, pp. 251-256
-
-
Devesa, J.1
Diaz, M.J.2
Tresguerres, J.A.3
-
76
-
-
0141517336
-
Neuroanatomical circuits modulating fear and anxiety behaviors
-
Charney DS. Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatr Scand 2003;108:38-50.
-
(2003)
Acta Psychiatr Scand
, vol.108
, pp. 38-50
-
-
Charney, D.S.1
-
77
-
-
9644281103
-
Anxious and depressive disorders and their comorbidity: Effect on central nervous system noradrenergic function
-
Cameron OG, Abelson JL, Young EA. Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function. Biol Psychiatry 2004;56: 875-883.
-
(2004)
Biol Psychiatry
, vol.56
, pp. 875-883
-
-
Cameron, O.G.1
Abelson, J.L.2
Young, E.A.3
-
78
-
-
48749115329
-
TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment
-
Li Y, Luikart BW, Birnbaum S, et al. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 2008;59:399-412.
-
(2008)
Neuron
, vol.59
, pp. 399-412
-
-
Li, Y.1
Luikart, B.W.2
Birnbaum, S.3
-
79
-
-
58149343358
-
Adult neurogenesis, mental health, and mental illness: Hope or hype?
-
Eisch AJ, Cameron HA, Encinas JM, et al. Adult neurogenesis, mental health, and mental illness: hope or hype? J Neurosci 2008;28:11785-11791.
-
(2008)
J Neurosci
, vol.28
, pp. 11785-11791
-
-
Eisch, A.J.1
Cameron, H.A.2
Encinas, J.M.3
-
80
-
-
35948999990
-
Neurobiology of depression: An integrated view of key findings
-
Maletic V, Robinson M, Oakes T, et al. Neurobiology of depression: an integrated view of key findings. Int J Clin Pract 2007;61:2030-2040.
-
(2007)
Int J Clin Pract
, vol.61
, pp. 2030-2040
-
-
Maletic, V.1
Robinson, M.2
Oakes, T.3
-
81
-
-
0028364703
-
Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus
-
Cameron HA, Gould E. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 1994;61:203-209.
-
(1994)
Neuroscience
, vol.61
, pp. 203-209
-
-
Cameron, H.A.1
Gould, E.2
-
82
-
-
0025933623
-
Adrenal steroids regulate postnatal development of the rat dentate gyrus: I. Effects of glucocorticoids on cell death
-
Gould E, Woolley CS, McEwen BS. Adrenal steroids regulate postnatal development of the rat dentate gyrus: I. Effects of glucocorticoids on cell death. J Comp Neurol 1991;313: 479-485.
-
(1991)
J Comp Neurol
, vol.313
, pp. 479-485
-
-
Gould, E.1
Woolley, C.S.2
McEwen, B.S.3
-
83
-
-
0024402424
-
Enhanced brain cell proliferation following early adrenalectomy in rats
-
Yehuda R, Fairman KR, Meyer JS. Enhanced brain cell proliferation following early adrenalectomy in rats. J Neurochem 1989;53:241-248.
-
(1989)
J Neurochem
, vol.53
, pp. 241-248
-
-
Yehuda, R.1
Fairman, K.R.2
Meyer, J.S.3
-
84
-
-
53149105916
-
Age-dependent effects of chronic stress on brain plasticity and depressive behavior
-
Toth E, Gersner R, Wilf-Yarkoni A, et al. Age-dependent effects of chronic stress on brain plasticity and depressive behavior. J Neurochem 2008;107:522-532.
-
(2008)
J Neurochem
, vol.107
, pp. 522-532
-
-
Toth, E.1
Gersner, R.2
Wilf-Yarkoni, A.3
-
85
-
-
44649160040
-
Brain-derived neurotropic factor and neurogenesis in the adult rat dentate gyrus: Interactions with corticosterone
-
Pinnock SB, Herbert J. Brain-derived neurotropic factor and neurogenesis in the adult rat dentate gyrus: interactions with corticosterone. Eur J Neurosci 2008;27:2493-2500.
-
(2008)
Eur J Neurosci
, vol.27
, pp. 2493-2500
-
-
Pinnock, S.B.1
Herbert, J.2
-
86
-
-
0036833778
-
Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus
-
Kulkarni VA, Jha S, Vaidya VA. Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus. Eur J Neurosci 2002;16:2008-2012.
-
(2002)
Eur J Neurosci
, vol.16
, pp. 2008-2012
-
-
Kulkarni, V.A.1
Jha, S.2
Vaidya, V.A.3
-
87
-
-
33644921003
-
Selective serotonin depletion does not regulate hippocampal neurogenesis in the adult rat brain: Differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine
-
Jha S, Rajendran R, Davda J, et al. Selective serotonin depletion does not regulate hippocampal neurogenesis in the adult rat brain: differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine. Brain Res 2006;1075:48-59.
-
(2006)
Brain Res
, vol.1075
, pp. 48-59
-
-
Jha, S.1
Rajendran, R.2
Davda, J.3
-
88
-
-
33745648114
-
The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells
-
Rizk P, Salazar J, Raisman-Vozari R, et al. The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology 2006;31:1146-1157.
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 1146-1157
-
-
Rizk, P.1
Salazar, J.2
Raisman-Vozari, R.3
-
89
-
-
49749101642
-
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications
-
Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008;64:527-532.
-
(2008)
Biol Psychiatry
, vol.64
, pp. 527-532
-
-
Sen, S.1
Duman, R.2
Sanacora, G.3
-
90
-
-
36549030795
-
Stress, depression, and neuroplasticity: A convergence of mechanisms
-
Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008; 33:88-109.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 88-109
-
-
Pittenger, C.1
Duman, R.S.2
-
91
-
-
35348849104
-
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein
-
Calabrese F, Molteni R, Maj PF, et al. Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 2007;32:2351-2359.
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 2351-2359
-
-
Calabrese, F.1
Molteni, R.2
Maj, P.F.3
-
92
-
-
33845334877
-
Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons
-
Chen MJ, Nguyen TV, Pike CJ, et al. Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. Cell Signal 2007;19:114-128.
-
(2007)
Cell Signal
, vol.19
, pp. 114-128
-
-
Chen, M.J.1
Nguyen, T.V.2
Pike, C.J.3
-
93
-
-
46649105672
-
Neurotrophin and neuropeptide expression in mouse brain is regulated by knockout of the norepinephrine transporter
-
Haenisch B, Gilsbach R, Bonisch H. Neurotrophin and neuropeptide expression in mouse brain is regulated by knockout of the norepinephrine transporter. J Neural Transm 2008; 115:973-982.
-
(2008)
J Neural Transm
, vol.115
, pp. 973-982
-
-
Haenisch, B.1
Gilsbach, R.2
Bonisch, H.3
-
94
-
-
40349107260
-
BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake
-
Mannari C, Origlia N, Scatena A, et al. BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake. Cell Mol Neurobiol 2008;28: 457-468.
-
(2008)
Cell Mol Neurobiol
, vol.28
, pp. 457-468
-
-
Mannari, C.1
Origlia, N.2
Scatena, A.3
-
95
-
-
45949106380
-
Noradrenergic innervation of the dorsal medial prefrontal cortex modulates hypothalamo-pituitary-adrenal responses to acute emotional stress
-
Radley JJ, Williams B, Sawchenko PE. Noradrenergic innervation of the dorsal medial prefrontal cortex modulates hypothalamo-pituitary-adrenal responses to acute emotional stress. J Neurosci 2008;28:5806-5816.
-
(2008)
J Neurosci
, vol.28
, pp. 5806-5816
-
-
Radley, J.J.1
Williams, B.2
Sawchenko, P.E.3
-
96
-
-
33745338513
-
Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus
-
Xu H, Chen Z, He J, et al. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 2006;16:551-559.
-
(2006)
Hippocampus
, vol.16
, pp. 551-559
-
-
Xu, H.1
Chen, Z.2
He, J.3
-
97
-
-
5044245302
-
Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine
-
Xu H, Luo C, Richardson JS, et al. Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine. Pharmacogenomics J 2004;4:322-331.
-
(2004)
Pharmacogenomics J
, vol.4
, pp. 322-331
-
-
Xu, H.1
Luo, C.2
Richardson, J.S.3
-
98
-
-
33748532898
-
Revenge of the"sit" how lifestyle impacts neuronal and cognitive health through molecular systems that interface energy metabolism with neuronal plasticity
-
Vaynman S, Gomez-Pinilla F. Revenge of the "sit": how lifestyle impacts neuronal and cognitive health through molecular systems that interface energy metabolism with neuronal plasticity. J Neurosci Res 2006;84:699-715.
-
(2006)
J Neurosci Res
, vol.84
, pp. 699-715
-
-
Vaynman, S.1
Gomez-Pinilla, F.2
-
99
-
-
28444447357
-
Neurotrophic factors and regulation of mood: Role of exercise, diet and metabolism
-
Duman RS. Neurotrophic factors and regulation of mood: role of exercise, diet and metabolism. Neurobiol Aging 2005;26: 88-93.
-
(2005)
Neurobiol Aging
, vol.26
, pp. 88-93
-
-
Duman, R.S.1
-
100
-
-
77953551359
-
Exercise for depression: Efficacy, safety and clinical trial implications
-
Dunlop BW, Self RL. Exercise for depression: efficacy, safety and clinical trial implications. Psychopharmacol Bull 2008;41: 65-75.
-
(2008)
Psychopharmacol Bull
, vol.41
, pp. 65-75
-
-
Dunlop, B.W.1
Self, R.L.2
-
101
-
-
67449116244
-
Physical activity, exercise, depression and anxiety disorders
-
Strohle A. Physical activity, exercise, depression and anxiety disorders. J Neural Transm 2009;116:777-784.
-
(2009)
J Neural Transm
, vol.116
, pp. 777-784
-
-
Strohle, A.1
-
102
-
-
0035007062
-
Physical activity dose-response effects on outcomes of depression and anxiety
-
discussion 609-610
-
Dunn AL, Trivedi MH, O'Neal HA. Physical activity dose-response effects on outcomes of depression and anxiety. Med Sci Sports Exerc 2001;33:S587-S597; discussion 609-610.
-
(2001)
Med Sci Sports Exerc
, vol.33
-
-
Dunn, A.L.1
Trivedi, M.H.2
O'neal, H.A.3
-
103
-
-
26044482076
-
Case history: The discovery of fluoxetine hydrochloride (Prozac)
-
Wong DT, Perry KW, Bymaster FP. Case history: the discovery of fluoxetine hydrochloride (Prozac). Nat Rev Drug Discov 2005;4:764-774.
-
(2005)
Nat Rev Drug Discov
, vol.4
, pp. 764-774
-
-
Wong, D.T.1
Perry, K.W.2
Bymaster, F.P.3
-
104
-
-
0034000512
-
Role of norepinephrine in depression
-
Delgado PL, Moreno FA. Role of norepinephrine in depression. J Clin Psychiatry 2000;61Supp 1:5-12.
-
(2000)
J Clin Psychiatry
, vol.61
, Issue.SUPPL. 1
, pp. 5-12
-
-
Delgado, P.L.1
Moreno, F.A.2
-
105
-
-
33646801936
-
Monoamine depletion studies: Implications for antidepressant discontinuation syndrome
-
Delgado PL. Monoamine depletion studies: implications for antidepressant discontinuation syndrome. J Clin Psychiatry 2006;67:22-26.
-
(2006)
J Clin Psychiatry
, vol.67
, pp. 22-26
-
-
Delgado, P.L.1
-
106
-
-
0028032353
-
Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients
-
Delgado PL, Price LH, Miller HL, et al. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 1994;51: 865-874.
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 865-874
-
-
Delgado, P.L.1
Price, L.H.2
Miller, H.L.3
-
107
-
-
0033032825
-
Tryptophandepletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action
-
Delgado PL, Miller HL, Salomon RM, et al. Tryptophandepletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 1999;46: 212-220.
-
(1999)
Biol Psychiatry
, vol.46
, pp. 212-220
-
-
Delgado, P.L.1
Miller, H.L.2
Salomon, R.M.3
-
108
-
-
0034049108
-
Depression: The case for a monoamine deficiency
-
Delgado PL. Depression: the case for a monoamine deficiency. J Clin Psychiatry 2000;61:7-11.
-
(2000)
J Clin Psychiatry
, vol.61
, pp. 7-11
-
-
Delgado, P.L.1
-
109
-
-
0030993317
-
The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments
-
Mongeau R, Blier P, de MC. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 1997;23:145-195.
-
(1997)
Brain Res Brain Res Rev
, vol.23
, pp. 145-195
-
-
Mongeau, R.1
Blier, P.2
De, M.C.3
-
110
-
-
0035570622
-
Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response
-
Blier P. Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response. J Psychiatry Neurosci 2001;26:S3-S10.
-
(2001)
J Psychiatry Neurosci
, vol.26
-
-
Blier, P.1
-
111
-
-
32844471211
-
Stress-induced plasticity of monoamine axons
-
Liu Y, Nakamura S. Stress-induced plasticity of monoamine axons. Front Biosci 2006;11:1794-1801.
-
(2006)
Front Biosci
, vol.11
, pp. 1794-1801
-
-
Liu, Y.1
Nakamura, S.2
-
112
-
-
0034816014
-
Rate-independent inhibition by norepinephrine of 5-HT release from the somadendritic region of serotonergic neurons
-
Kalsner S, Abdali SA. Rate-independent inhibition by norepinephrine of 5-HT release from the somadendritic region of serotonergic neurons. Brain Res Bull 2001;55: 761-765.
-
(2001)
Brain Res Bull
, vol.55
, pp. 761-765
-
-
Kalsner, S.1
Abdali, S.A.2
-
113
-
-
1442314728
-
Selective noradrenaline reuptake inhibition enhances serotonergic neuronal activity and transmitter release in the rat forebrain
-
Linner L, Wiker C, Arborelius L, et al. Selective noradrenaline reuptake inhibition enhances serotonergic neuronal activity and transmitter release in the rat forebrain. J Neural Transm 2004;111:127-139.
-
(2004)
J Neural Transm
, vol.111
, pp. 127-139
-
-
Linner, L.1
Wiker, C.2
Arborelius, L.3
-
114
-
-
33749362591
-
Treatment of posttraumatic stress disorder with venlafaxine extended release: A 6-month randomized controlled trial
-
Davidson J, Baldwin D, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry 2006;63:1158-1165.
-
(2006)
Arch Gen Psychiatry
, vol.63
, pp. 1158-1165
-
-
Davidson, J.1
Baldwin, D.2
Stein, D.J.3
-
115
-
-
34948830502
-
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents
-
Papakostas GI, Thase ME, Fava M, et al. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol Psychiat 2007; 62:1217-1227.
-
(2007)
Biol Psychiat
, vol.62
, pp. 1217-1227
-
-
Papakostas, G.I.1
Thase, M.E.2
Fava, M.3
-
116
-
-
0142169481
-
Antagonism of the stressinduced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine
-
Dazzi L, Seu E, Cherchi G, et al. Antagonism of the stressinduced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine. Eur J Pharm 2003;476:55-61.
-
(2003)
Eur J Pharm
, vol.476
, pp. 55-61
-
-
Dazzi, L.1
Seu, E.2
Cherchi, G.3
-
117
-
-
0033769570
-
Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression
-
Harkin A, Nally R, Kelly JP, et al. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression. J Neural Transm 2000;107: 1213-1227.
-
(2000)
J Neural Transm
, vol.107
, pp. 1213-1227
-
-
Harkin, A.1
Nally, R.2
Kelly, J.P.3
-
118
-
-
0030900751
-
Noradrenaline in basic models of depression
-
Leonard BE. Noradrenaline in basic models of depression. Eur Neuropsychopharmacol 1997;7Supp 1:S11-S16.
-
(1997)
Eur Neuropsychopharmacol
, vol.7
, Issue.SUPPL 1
-
-
Leonard, B.E.1
-
119
-
-
0036186943
-
Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression
-
Ferguson JM, Mendels J, Schwart GE. Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression. Int Clin Psychopharmacol 2002;17:45-51.
-
(2002)
Int Clin Psychopharmacol
, vol.17
, pp. 45-51
-
-
Ferguson, J.M.1
Mendels, J.2
Schwart, G.E.3
-
120
-
-
0036327422
-
Effects of reboxetine on anxiety, agitation, and insomnia: Results of a pooled evaluation of randomized clinical trials
-
Stahl SM,Mendels J, Schwartz GE. Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials. J Clin Psychopharmacol 2002;22:388-392.
-
(2002)
J Clin Psychopharmacol
, vol.22
, pp. 388-392
-
-
Stahl Smmendels, J.1
Schwartz, G.E.2
-
121
-
-
17544404431
-
Reboxetine: A pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
-
Wong EH, Sonders MS, Amara SG, et al. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry 2000;47:818-829.
-
(2000)
Biol Psychiatry
, vol.47
, pp. 818-829
-
-
Wong, E.H.1
Sonders, M.S.2
Amara, S.G.3
-
122
-
-
0035062786
-
Noradernergic dysfunction and antidepressant treatment response
-
Correa H, Duval F, Claude MM, et al. Noradernergic dysfunction and antidepressant treatment response. Eur Neuropsychopharmacol 2001;11:163-168.
-
(2001)
Eur Neuropsychopharmacol
, vol.11
, pp. 163-168
-
-
Correa, H.1
Duval, F.2
Claude, M.M.3
-
123
-
-
0032981063
-
Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding
-
Sanchez C, Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 1999;19:467-489.
-
(1999)
Cell Mol Neurobiol
, vol.19
, pp. 467-489
-
-
Sanchez, C.1
Hyttel, J.2
-
124
-
-
85047103327
-
Amitriptyline: Dual-action antidepressant?
-
author reply 1391-1392
-
Gillman PK. Amitriptyline: dual-action antidepressant? J Clin Psychiatry 2003;64:1391; author reply 1391-1392.
-
(2003)
J Clin Psychiatry
, vol.64
, pp. 1391
-
-
Gillman, P.K.1
-
125
-
-
34547883177
-
Comorbid anxiety corresponds with neuropsychological dysfunction in unipolar depression
-
Basso MR, Lowery N, Ghormley C, et al. Comorbid anxiety corresponds with neuropsychological dysfunction in unipolar depression. Cogn Neuropsychiatry 2007;12:437-456.
-
(2007)
Cogn Neuropsychiatry
, vol.12
, pp. 437-456
-
-
Basso, M.R.1
Lowery, N.2
Ghormley, C.3
-
126
-
-
37349038945
-
A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults
-
Castaneda AE, Tuulio-Henriksson A,MarttunenM, et al. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 2008;106:1-27.
-
(2008)
J Affect Disord
, vol.106
, pp. 1-27
-
-
Castaneda, A.E.1
Tuulio-Henriksson, A.2
Marttunen, M.3
-
127
-
-
47749154418
-
The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: An unaccounted source of variance in clinical trials
-
Gualtieri CT, Morgan DW. The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials. J Clin Psychiatry 2008;69:1122-1130.
-
(2008)
J Clin Psychiatry
, vol.69
, pp. 1122-1130
-
-
Gualtieri, C.T.1
Morgan, D.W.2
-
128
-
-
33847631254
-
Adrenergic pharmacology and cognition: Focus on the prefrontal cortex
-
Ramos BP, Arnsten AF. Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol Ther 2007;113: 523-536.
-
(2007)
Pharmacol Ther
, vol.113
, pp. 523-536
-
-
Ramos, B.P.1
Arnsten, A.F.2
-
129
-
-
29444435601
-
Update on augmentation of antidepressant response in resistant depression
-
DeBattista CLA.Update on augmentation of antidepressant response in resistant depression. Curr Psychiatry Rep 2005;7:435-440.
-
(2005)
Curr Psychiatry Rep
, vol.7
, pp. 435-440
-
-
Debattista, C.L.A.1
-
130
-
-
33645904173
-
Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats
-
Pandaranandaka J, Poonyachoti S, Kalandakanond-Thongsong S. Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats. Physiol Behav 2006;87:828-835.
-
(2006)
Physiol Behav
, vol.87
, pp. 828-835
-
-
Pandaranandaka, J.1
Poonyachoti, S.2
Kalandakanond-Thongsong, S.3
-
131
-
-
61649119848
-
Experience of the use of velaxin (venlafaxine) in anxious depression
-
Il'ina NA. Experience of the use of velaxin (venlafaxine) in anxious depression. Neurosci Behav Physiol 2009;39: 305-309.
-
(2009)
Neurosci Behav Physiol
, vol.39
, pp. 305-309
-
-
Il'ina, N.A.1
-
132
-
-
49149084555
-
Managing the patient with co-morbid depression and an anxiety disorder
-
Schoevers RA, Van HL, Koppelmans V, et al. Managing the patient with co-morbid depression and an anxiety disorder. Drugs 2008;68:1621-1634.
-
(2008)
Drugs
, vol.68
, pp. 1621-1634
-
-
Schoevers, R.A.1
Van, H.L.2
Koppelmans, V.3
-
133
-
-
0141731324
-
Duloxetine in treatment of anxiety symptoms associated with depression
-
Dunner DL, Goldstein DJ, Mallinckrodt C, et al. Duloxetine in treatment of anxiety symptoms associated with depression. Depress Anxiety 2003;18:53-61.
-
(2003)
Depress Anxiety
, vol.18
, pp. 53-61
-
-
Dunner, D.L.1
Goldstein, D.J.2
Mallinckrodt, C.3
-
134
-
-
67651030466
-
Strategies to enhance the therapeutic efficacy of antidepressants: Targeting residual symptoms
-
Kurian BT, Greer TL, Trivedi MH. Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms. Expert Rev Neurother 2009;9:975-984.
-
(2009)
Expert Rev Neurother
, vol.9
, pp. 975-984
-
-
Kurian, B.T.1
Greer, T.L.2
Trivedi, M.H.3
-
135
-
-
33750208351
-
Pharmacological approaches to the treatment of residual symptoms
-
Fava M. Pharmacological approaches to the treatment of residual symptoms. J Psychopharmacol 2006;20: 29-34.
-
(2006)
J Psychopharmacol
, vol.20
, pp. 29-34
-
-
Fava, M.1
-
136
-
-
0025372241
-
Efficacy of continuation drug therapy of depression and anxiety: Issues and methodologies
-
Prien RF. Efficacy of continuation drug therapy of depression and anxiety: issues and methodologies. J Clin Psychopharmacol 1990;10:86S-90S.
-
(1990)
J Clin Psychopharmacol
, vol.10
-
-
Prien, R.F.1
|